Communiqués Bayer AG

Actions

BAYN

DE000BAY0017

Marché Fermé - Xetra Autres places de cotation 17:35:18 06/06/2024			Pré-ouverture 07:32:01
28,38 ^EUR	-0,73 %		28,28	-0,39 %

06/06	Bayer : travaille avec PAPACKS pour des emballages durables	CF
06/06	BAYER AG : DZ Bank toujours à l'achat	ZD

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	23/05	EQ
Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	22/05	EQ
Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	21/05	EQ
Bayer : Q1 Media Update	14/05	PU
Bayer : First-quarter performance as expected	14/05	PU
Bayer : Debt Investor Information FY 2023 / Q1 2024 (DE)	14/05	PU
Bayer : Debt Investor Information FY 2023 Q1 204	14/05	PU
Bayer : Quarterly Statement First Quarter 2024	14/05	PU
Bayer : Address by Bill Anderson	26/04	PU
Bayer : Address by Bill Anderson	22/04	PU
Bayer : Explanations to the Supervisory Board Report - Prof. Dr. Norbert Winkeljohann	22/04	PU
Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	17/04	EQ
Bayer - AskBio Names Mansuo Shannon Chief Scientific Officer	10/04	AQ
Bayer and Vividion Therapeutics to highlight advancing oncology portfolio at AACR 2024 Annual Meeting	04/04	AQ
Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	03/04	EQ
Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	27/03	EQ
Bayer Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	22/03	EQ
Bayer Pharmaceuticals streamlines Leadership Team for next phase of growth	21/03	AQ
Bayer - Positive topline results from Phase III long-term study OASIS 3 support submissions for marketing authorization for Bayer's elinzanetant	20/03	AQ
Bayer AG and Lavie Bio Continue for Second Year of Biofungicides Validation Following Successful Lab and Greenhouse Testing - Evogene	20/03	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

A la une

BAYER : Aussi doux que prévu

Le 14 mai 2024 à 20:12

Bayer AG : Pas au bout de ses peines

Le 06 mars 2024 à 13:58